194 related articles for article (PubMed ID: 34373577)
1. RAC1 plays an essential role in estrogen receptor alpha function in breast cancer cells.
Sun J; Gaidosh G; Xu Y; Mookhtiar A; Man N; Cingaram PR; Blumenthal E; Shiekhattar R; Goka ET; Nimer SD; Lippman ME
Oncogene; 2021 Oct; 40(40):5950-5962. PubMed ID: 34373577
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the Rho GTPase, Rac1, decreases estrogen receptor levels and is a novel therapeutic strategy in breast cancer.
Rosenblatt AE; Garcia MI; Lyons L; Xie Y; Maiorino C; Désiré L; Slingerland J; Burnstein KL
Endocr Relat Cancer; 2011 Apr; 18(2):207-19. PubMed ID: 21118977
[TBL] [Abstract][Full Text] [Related]
3. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix, Rac1 signaling, and estrogen-induced proliferation in MCF-7 breast cancer cells.
Xie JW; Haslam SZ
Breast Cancer Res Treat; 2008 Jul; 110(2):257-68. PubMed ID: 17851761
[TBL] [Abstract][Full Text] [Related]
5. PARP-1 Regulates Estrogen-Dependent Gene Expression in Estrogen Receptor α-Positive Breast Cancer Cells.
Gadad SS; Camacho CV; Malladi V; Hutti CR; Nagari A; Kraus WL
Mol Cancer Res; 2021 Oct; 19(10):1688-1698. PubMed ID: 34158394
[TBL] [Abstract][Full Text] [Related]
6. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Rac1 GTPase downregulates vascular endothelial growth factor receptor-2 expression by suppressing Sp1-dependent DNA binding in human endothelial cells.
Meissner M; Michailidou D; Stein M; Hrgovic I; Kaufmann R; Gille J
Exp Dermatol; 2009 Oct; 18(10):863-9. PubMed ID: 19469899
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the Pol II CTD Phosphorylation Code by Rac1 and Cdc42 Small GTPases in Cultured Human Cancer Cells and Its Implication for Developing a Synthetic-Lethal Cancer Therapy.
Zhang B; Zhong X; Sauane M; Zhao Y; Zheng ZL
Cells; 2020 Mar; 9(3):. PubMed ID: 32143485
[TBL] [Abstract][Full Text] [Related]
9. Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation.
Tanaka S; Fukumoto Y; Nochioka K; Minami T; Kudo S; Shiba N; Takai Y; Williams CL; Liao JK; Shimokawa H
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1591-600. PubMed ID: 23640485
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of NADPH oxidase activation by the Rac/Rho-GDI complex.
Di-Poï N; Fauré J; Grizot S; Molnár G; Pick E; Dagher MC
Biochemistry; 2001 Aug; 40(34):10014-22. PubMed ID: 11513579
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the Rac1-RhoGDI complex involved in nadph oxidase activation.
Grizot S; Fauré J; Fieschi F; Vignais PV; Dagher MC; Pebay-Peyroula E
Biochemistry; 2001 Aug; 40(34):10007-13. PubMed ID: 11513578
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer.
McDermott MS; Chumanevich AA; Lim CU; Liang J; Chen M; Altilia S; Oliver D; Rae JM; Shtutman M; Kiaris H; Győrffy B; Roninson IB; Broude EV
Oncotarget; 2017 Feb; 8(8):12558-12575. PubMed ID: 28147342
[TBL] [Abstract][Full Text] [Related]
13. K-Ras mediated murine epidermal tumorigenesis is dependent upon and associated with elevated Rac1 activity.
Samuel MS; Lourenço FC; Olson MF
PLoS One; 2011 Feb; 6(2):e17143. PubMed ID: 21358804
[TBL] [Abstract][Full Text] [Related]
14. Rho GDP dissociation inhibitor alpha interacts with estrogen receptor alpha and influences estrogen responsiveness.
El Marzouk S; Schultz-Norton JR; Likhite VS; McLeod IX; Yates JR; Nardulli AM
J Mol Endocrinol; 2007 Oct; 39(4):249-59. PubMed ID: 17909265
[TBL] [Abstract][Full Text] [Related]
15. Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α.
Barone I; Brusco L; Gu G; Selever J; Beyer A; Covington KR; Tsimelzon A; Wang T; Hilsenbeck SG; Chamness GC; Andò S; Fuqua SA
J Natl Cancer Inst; 2011 Apr; 103(7):538-52. PubMed ID: 21447808
[TBL] [Abstract][Full Text] [Related]
16. Cullin-3/KCTD10 E3 complex is essential for Rac1 activation through RhoB degradation in human epidermal growth factor receptor 2-positive breast cancer cells.
Murakami A; Maekawa M; Kawai K; Nakayama J; Araki N; Semba K; Taguchi T; Kamei Y; Takada Y; Higashiyama S
Cancer Sci; 2019 Feb; 110(2):650-661. PubMed ID: 30515933
[TBL] [Abstract][Full Text] [Related]
17. Rac1 signaling modulates BCL-6-mediated repression of gene transcription.
Barros P; Jordan P; Matos P
Mol Cell Biol; 2009 Aug; 29(15):4156-66. PubMed ID: 19487462
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks.
Banerjee S; Sengupta K; Saxena NK; Dhar K; Banerjee SK
Mol Cancer Res; 2005 Mar; 3(3):151-62. PubMed ID: 15798095
[TBL] [Abstract][Full Text] [Related]
19. The Phosphatidylinositol (3,4,5)-Trisphosphate-dependent Rac Exchanger 1·Ras-related C3 Botulinum Toxin Substrate 1 (P-Rex1·Rac1) Complex Reveals the Basis of Rac1 Activation in Breast Cancer Cells.
Lucato CM; Halls ML; Ooms LM; Liu HJ; Mitchell CA; Whisstock JC; Ellisdon AM
J Biol Chem; 2015 Aug; 290(34):20827-20840. PubMed ID: 26112412
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
Esufali S; Bapat B
Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
